Literature DB >> 27000415

A critical appraisal of transanal minimally invasive surgery (TAMIS) in the treatment of rectal adenoma: a 4-year experience with 51 cases.

Sven-Petter Haugvik1, Sigrid Groven1, Johan Bondi1, Torolf Vågan2, Stig Ove Brynhildsvoll2, Ole Christian Olsen1.   

Abstract

OBJECTIVE: The aim of this study was to describe feasibility, postoperative morbidity, and histological outcome of transanal minimally-invasive surgery (TAMIS) in patients with rectal adenoma.
MATERIAL AND METHODS: All patients who underwent TAMIS at a single institution from December 2011 to December 2015 were retrospectively included in the study. Feasibility was based on tumor size, distance of tumor from the anal verge, operative time, and hospital stay. Thirty-day morbidity was defined by the revised Accordion Classification system. Histological outcome included microscopic resection margin status, specimen fragmentation status, and grading of dysplasia in rectal adenoma.
RESULTS: A total of 51 patients with rectal adenoma underwent TAMIS. The median tumor diameter was 32 (4-60) mm and the median distance from the anal verge 8 (3-14) cm. Median operative time was 40 (13-116) min and median length of hospital stay was 1 (0-25) days. Overall morbidity was 12% (four grade 1, one grade 2, and one grade 3 complications). 22% had a positive resection margin, whereas 31% had an indefinable resection margin status mostly due to tissue fragmentation. Median follow-up time was 7 (0-40) months.
CONCLUSIONS: TAMIS is a challenging surgical technique for treatment of rectal adenoma. Our initial experience among 51 patients resulted in a high proportion of positive resection margins and a high fragmentation rate. The role of TAMIS in the treatment of rectal adenoma is to be defined through comparative studies.

Entities:  

Keywords:  Histology; minimally invasive surgical procedures; postoperative complications; rectal neoplasms; resection margin

Mesh:

Year:  2016        PMID: 27000415     DOI: 10.3109/00365521.2016.1157891

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Transanal minimal invasive surgery (TAMIS): safety and feasibility for the resection of benign and malignant lesions of the rectum.

Authors:  Asif Mehraj; Najmus Saqib; Rauf Wani; Nisar Chowdri; Fazl Parray; Mudassir Khan
Journal:  Turk J Surg       Date:  2021-03-22

2.  Transanal minimally invasive surgery for benign large rectal polyps and early malignant rectal cancers: experience and outcomes from the first Canadian centre to adopt the technique.

Authors:  Antonio Caycedo-Marulanda; Henry Y Jiang; Erica L Kohtakangas
Journal:  Can J Surg       Date:  2017-12       Impact factor: 2.089

3.  Transanal minimally invasive surgery (TAMIS) for rectal tumor: a case report and literature review.

Authors:  Huipeng Wang; Tao Ye; Jun Chen; Lifeng Gong; Wenjie Chen; Jiamen Shen; Jiaying Zhao; Yuankun Cai
Journal:  Ann Transl Med       Date:  2020-09

4.  Implementation of transanal minimally invasive surgery (TAMIS) for rectal neoplasms: results from a single centre.

Authors:  W Lossius; T Stornes; T E Bernstein; A Wibe
Journal:  Tech Coloproctol       Date:  2021-12-14       Impact factor: 3.781

5.  Transanal Minimally Invasive Surgery for Rectal Lesions.

Authors:  Silvia Quaresima; Andrea Balla; Luana Franceschilli; Marco La Torre; Corrado Iafrate; Mostafa Shalaby; Nicola Di Lorenzo; Pierpaolo Sileri
Journal:  JSLS       Date:  2016 Jul-Sep       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.